Tonix Pharma (TNXP) Misses Q2 EPS by 215c

Tonix Pharma (NASDAQ: TNXP) reported Q2 EPS of ($2.68), $2.15 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Summit Hotel Properties refinances $650M credit facility through 2031
• After-Hours Stock Movers: NKE, BE, STZ, RIG